Search research articles
Contact Us
Filters
Showing results (31-40 of 48) with videos related to
Page
of 5
Sort By:
Clinical Pharmacology and Therapeutics
|
March 31, 2019
A Comparative Study of Longitudinal Toxicities of Cytotoxic Drugs, Molecularly Targeted Agents, Immunomodulatory Drugs, and Cancer Vaccines
Akihiro Hirakawa, Kazuki Sudo, Kan Yonemori, et al.
Clinical Pharmacology and Therapeutics
|
March 1, 2020
MASTER KEY Project: Powering Clinical Development for Rare Cancers Through a Platform Trial
Hitomi S Okuma, Kan Yonemori, Shoko N Narita, et al.
British Journal of Cancer
|
July 15, 2016
Clinical and microarray analysis of breast cancers of all subtypes from two prospective preoperative chemotherapy studies
H S Okuma, F Koizumi, A Hirakawa, et al.
British Journal of Cancer
|
February 20, 2022
Comprehensive screening for drugs that modify radiation-induced immune responses
Masayuki Okumura, Junyan Du, Shun-Ichiro Kageyama, et al.
Oncology
|
February 4, 2025
Treatment and Reasons for Choosing Treatment in Breast Cancer Patients Who Underwent Next-Generation Sequencing Test
Rumi Nishimura, Kazuki Sudo, Rui Kitadai, et al.
JCO Precision Oncology
|
May 26, 2021
Impact of ALK Inhibitors in Patients With <i>ALK</i>-Rearranged Nonlung Solid Tumors
Yuki Takeyasu, Hitomi S Okuma, Yuki Kojima, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 11, 2023
Phase II Trial of Nivolumab in Metastatic Rare Cancer with dMMR or MSI-H and Relation with Immune Phenotypic Analysis (the ROCK Trial)
Hitomi S Okuma, Keisuke Watanabe, Kenji Tsuchihashi, et al.
Diagnostics (Basel, Switzerland)
|
June 28, 2023
Development of a Detection System for <i>ESR1</i> Mutations in Circulating Tumour DNA Using PNA-LNA-Mediated PCR Clamping
Yuki Kojima, Emi Noguchi, Tomomi Yoshino, et al.
ESMO Real World Data and Digital Oncology
|
February 6, 2026
Cancer registry as external control data for regulatory submission in Japan
H Bando, N Okita, Y Sakamoto, et al.
Oncology
|
April 11, 2022
Poor Treatment Outcomes with Second-Line Chemotherapy in Advanced Synovial Sarcoma
Yuki Kojima, Tatsunori Shimoi, Takuji Seo, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 48) with videos related to
Sort By:
Page
of 5
Clinical Pharmacology and Therapeutics
|
March 31, 2019
A Comparative Study of Longitudinal Toxicities of Cytotoxic Drugs, Molecularly Targeted Agents, Immunomodulatory Drugs, and Cancer Vaccines
Akihiro Hirakawa, Kazuki Sudo, Kan Yonemori, et al.
Clinical Pharmacology and Therapeutics
|
March 1, 2020
MASTER KEY Project: Powering Clinical Development for Rare Cancers Through a Platform Trial
Hitomi S Okuma, Kan Yonemori, Shoko N Narita, et al.
British Journal of Cancer
|
July 15, 2016
Clinical and microarray analysis of breast cancers of all subtypes from two prospective preoperative chemotherapy studies
H S Okuma, F Koizumi, A Hirakawa, et al.
British Journal of Cancer
|
February 20, 2022
Comprehensive screening for drugs that modify radiation-induced immune responses
Masayuki Okumura, Junyan Du, Shun-Ichiro Kageyama, et al.
Oncology
|
February 4, 2025
Treatment and Reasons for Choosing Treatment in Breast Cancer Patients Who Underwent Next-Generation Sequencing Test
Rumi Nishimura, Kazuki Sudo, Rui Kitadai, et al.
JCO Precision Oncology
|
May 26, 2021
Impact of ALK Inhibitors in Patients With <i>ALK</i>-Rearranged Nonlung Solid Tumors
Yuki Takeyasu, Hitomi S Okuma, Yuki Kojima, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 11, 2023
Phase II Trial of Nivolumab in Metastatic Rare Cancer with dMMR or MSI-H and Relation with Immune Phenotypic Analysis (the ROCK Trial)
Hitomi S Okuma, Keisuke Watanabe, Kenji Tsuchihashi, et al.
Diagnostics (Basel, Switzerland)
|
June 28, 2023
Development of a Detection System for <i>ESR1</i> Mutations in Circulating Tumour DNA Using PNA-LNA-Mediated PCR Clamping
Yuki Kojima, Emi Noguchi, Tomomi Yoshino, et al.
ESMO Real World Data and Digital Oncology
|
February 6, 2026
Cancer registry as external control data for regulatory submission in Japan
H Bando, N Okita, Y Sakamoto, et al.
Oncology
|
April 11, 2022
Poor Treatment Outcomes with Second-Line Chemotherapy in Advanced Synovial Sarcoma
Yuki Kojima, Tatsunori Shimoi, Takuji Seo, et al.
Page
of 5